JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M310540200 on December 3, 2003

J. Biol. Chem., Vol. 279, Issue 9, 8063-8069, February 27, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
279/9/8063    most recent
M310540200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, M.
Right arrow Articles by Burmester, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, M.
Right arrow Articles by Burmester, T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cytoglobin Is a Respiratory Protein in Connective Tissue and Neurons, Which Is Up-regulated by Hypoxia*

Marc Schmidt{ddagger}, Frank Gerlach§, Aaron Avivi¶, Tilmann Laufs§, Sylvia Wystub§, Jeremy C. Simpson||, Eviatar Nevo¶, Sigrid Saaler-Reinhardt**, Stefan Reuss{ddagger}{ddagger}, Thomas Hankeln§§§, and Thorsten Burmester{ddagger}§§¶¶

From the {ddagger}Institute of Zoology, the §Institute of Molecular Genetics, the **Institute of Physiological Chemistry, and the {ddagger}{ddagger}Department of Anatomy, Johannes Gutenberg-University, D-55099 Mainz, Germany, the Institute of Evolution, University of Haifa, Mt. Carmel, Haifa 31905, Israel, and ||Cell Biology and Biophysics, European Molecular Biology Laboratory, D-69117 Heidelberg, Germany

Received for publication, September 23, 2003 , and in revised form, December 2, 2003.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Cytoglobin is a recently discovered vertebrate globin distantly related to myoglobin, and its function is unknown. Here we present the first detailed analysis of the distribution and expression of cytoglobin. Northern and Western blotting experiments show the presence of cytoglobin mRNA and protein in a broad range of tissues. Quantitative PCR demonstrates an up-regulation of cytoglobin mRNA levels in rat heart and liver under hypoxic conditions (22 and 44 h of 9% oxygen). Immunofluorescence studies with three antibodies directed against different epitopes of the protein consistently show cytoglobin in connective tissue fibroblasts as well as in hepatic stellate cells. Cytoglobin is also present in chondroblasts and osteoblasts and shows a decreased level of expression upon differentiation to chondrocytes and osteocytes. Cytoglobin is located in the cytoplasm of these cell types. Evidence against an exclusively nuclear localization of cytoglobin, as recently proposed, is also provided by transfection assays with green fluorescent protein fusion constructs, which demonstrates the absence of an active nuclear import. The differential expression of cytoglobin argues against a general respiratory function of this molecule, but rather indicates a connective tissue-specific function. We hypothesize that cytoglobin may be involved in collagen synthesis. Cytoglobin expression was also observed in some neuronal subpopulations of the central and the peripheral nervous systems. Surprisingly, cytoglobin is localized in both the cytoplasm and nucleus of neurons, indicating a possible additional role of this protein in neuronal tissues.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Globins are small heme-containing proteins that have the ability to bind O2 and other gaseous ligands (1). Most globins efficiently capture and deliver O2, thus sustaining the aerobic metabolism of the respiratory chain (2-6). Some globins may also act as enzymes utilizing molecular O2 in oxidation reactions (7, 8). Vertebrates harbor four distinct globin types that differ in tissue distribution and function. The heterotetrameric hemoglobin facilitates the transport of O2 in the red blood cells of the circulatory system (1). The myocytes of the cardiac and striated muscles contain myoglobin, a monomeric protein that enhances O2 diffusion to the mitochondria of this metabolically highly active tissue and acts as a temporal O2 store (4-6). Myoglobin may also act as an NO dioxygenase (8). A respiratory function has also been attributed to neuroglobin (Ngb),1 a recently described vertebrate monomeric globin (9) that is expressed in neurons of the central and peripheral nervous systems (9-11). Ngb is also present in endocrine tissues (10), and a particularly high Ngb concentration was observed in the mammalian retina (12).

Most recently, cytoglobin (Cygb) has been identified as the fourth member of the vertebrate globin family. Cygb has been identified in the expressed sequence tag (EST) databases from mouse, man, and zebrafish and was found to be expressed in a broad range of mammalian tissues (13-14). In an independent study, Kawada et al. (15) had characterized the rat homologue of Cygb as a heme protein that shows enhanced expression in the stellate cells of the fibrotic liver, thus dubbing it "stellate cell activation-associated protein" or STAP (15, 16). Cygb binds O2 reversibly via the Fe2+ ion of the heme group (14-18). Similar to some plant hemoglobins, Ngb and some other globins (19), recombinant Cygb displays a hexacoordinated hemochrome structure of the Fe2+ in the deoxy form (14, 17, 18). Mammalian Cygb has the highest degree of sequence conservation observed among the vertebrate globins, with mouse and human Cygb differing in only 4.7% of the amino acids (13). Phylogenetic analyses suggest that Cygb and myoglobin form a common clade, which is distinct from neuroglobin and hemoglobin and originated from a globin common ancestor more than 450 million years ago (13, 20). Mammalian Cygb is longer than most globins and covers 190 amino acids instead of the typical 140-150 amino acids. This is due to two ~20 amino acid extensions at both the N and the C terminus. Nevertheless, the globin fold consisting of eight {alpha}-helices, and important globin-specific residues involved in O2 binding are conserved in the Cygb protein (20, 21). In addition to the globin-typical introns at positions B12.2 (i.e. between codon positions 2 and 3 of the 12th amino acid of the B-helix) and G7.0, the mammalian Cygb genes contain an intron downstream of the H helix (HC11.2), close to the 3'-end of the coding region. This 3' exon is absent in fish and may have been acquired later in tetrapod evolution (13).

The role of Cygb in the vertebrate metabolism is essentially unknown, although several putative functions have been proposed (13-15, 20, 22). Similar to myoglobin in the muscle, Cygb may facilitate O2 diffusion to the mitochondria. Cygb may also act as a regulatory protein that senses changes in O2 concentration, protects cells from reactive oxygen species, or, like some other globins, carries out enzymatic functions such as NADH oxidase, NO dioxygenase, or catalase (20). In view of these speculations, the understanding of Cygb function requires a detailed knowledge of its localization in different organs and cells. However, the available data are conflicting in terms of cellular and subcellular Cygb distribution (15, 16, 22). We therefore conducted a detailed study on Cygb localization and its regulation by hypoxia.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Animals—Adult mice (Balb/C) used in this study were maintained under constant conditions (light:dark cycle 12:12 h, room temperature 21 ± 1 °C) with food and water ad libitum. Animal handling and experiments were conducted according to a protocol that was approved by the county government office (Bezirksregierung Rheinhessen-Pfalz, Az 177-07/961-30). The mice were anesthetized with tribromoethanol (0.3 g/kg body weight) and were transcardially perfused with 100 ml of 0.1 M phosphate-buffered saline (PBS) at room temperature, with 15,000 IU of heparin/liter added. Perfusion-fixation was carried out at a constant rate of 10 ml/min with 200-300 ml of ice-cold 4% paraformaldehyde, 1.37% L-lysine, 0.21% sodium periodate in PBS (23). The right atrium was opened to enable venous outflow. Selected tissues and organs were immediately removed, postfixed for 1 h in the same fixative, and stored at 4 °C in phosphate-buffered 30% sucrose. Bones were decalcified in 12.5% EDTA (Mallinckrodt, Hennef, Germany) in distilled water (pH 7.2-7.4) for several days at room temperature with gentle agitation.

White rats (Rattus norvegicus) with a weight of ~150 g were kept in individual cages under controlled temperature conditions of 22-24 °C. Hypoxia was achieved by incubating the rats for 22 or 44 h in a sealed chamber (70/70/50 cm), which was constantly flushed at 3.5 liters/min with a premixed gas containing 9% oxygen. The rats were killed by intramuscular injection of Imalgene 100 (100 mg/kg of body weight; Rhone-Merieux, France). Heart and liver tissues were immediately taken and frozen in liquid nitrogen.

Antibody Preparation—Polyclonal antibodies were raised in rabbits against synthetic peptides that had been designed according to conserved regions of human and mouse Cygb (Fig. 1A). The antibodies are directed against the amino acid positions 2-16 of the N terminus ({alpha}Cygb1: H2N-EKVPGEMEIERRERS-CONH2), 66-80 ({alpha}Cygb2: H2N-MEDPLEMERSPQLRK-CONH2), or 92-106 ({alpha}Cygb3: H2N-VVENL-HDPDKVSSVL-CONH2) of the middle region, or 175-190 of the C terminus ({alpha}Cygb4: H2N-PNATTPPATLPSSGP-CONH2). Each of the antibodies was purified from the serum using the appropriate synthetic peptide coupled to a SulfoLink column (Pierce), following the manufacturer's instructions, and stored at 4 °C in 50 mM Tris, 100 mM glycine, pH ~7.4, supplemented with 0.1% NaN3.



View larger version (29K):
[in this window]
[in a new window]
  		FIG. 1.
Western blot analysis of Cygb protein in mouse tissues. A, four antibodies were raised in rabbits against synthetic peptides. B, {alpha}Cygb2 was used to detect Cygb in tissue extracts (50 µg of total protein) from gut, heart, brain, liver, lung, spleen, skeletal muscle, and retina. The recombinant protein (~100 ng) is loaded on the right lane (Cygb). The molecular mass marker is given on the left-hand side, the arrow indicates the position of Cygb.

 
ELISA (enzyme-linked immunosorbent assay)—ELISA plates were coated by 2 h of incubation with 50 ng of Cygb in PBS. The plates were blocked for 1 h with 1% bovine serum albumin in PBS and subsequently washed three times with PBST (PBS supplemented with 0.05% Tween 20). Antibody incubation was carried out overnight at 4 °C. The plates were washed three times with PBST, and incubated for 90 min at 37 °C with a horseradish peroxidase-conjugated goat anti-rabbit antibody (Dianova), diluted 1:10,000 in PBS. After additional washings, the bound antibody was quantified by staining in 1 mg/ml o-phenylenediamine dissolved in phosphate-citrate buffer, pH 5.0, 0.05% H2O2. After 30 min, the reaction was stopped by addition of 25 µlof4.5 M H2SO4 per well, and the absorption was read at 492 nm.

Western Blotting—Selected tissues were homogenized in PBS and supplemented with an equal volume of sample buffer (65 mM Tris-HCl, pH 6.8, 1% SDS, 5% {beta}-mercaptoethanol, 10% glycerol). After heat denaturation at 95 °C for 5 min, the protein samples (50 µg of total protein) were loaded to a 14% SDS-polyacrylamide gel. Antibody detection was carried out on protein samples transferred to nitrocellulose for 2 h at 0.8 mA/cm2. Nonspecific binding sites were blocked by incubation for 2 h with 2% nonfat dry milk in TBST (10 mM Tris-HCl, pH 7.4, 140 mM NaCl, 0.3% Tween-20). The membranes were incubated overnight with anti-Cygb antibodies, diluted 1:1000 in 2% milk/TBST. The membranes were washed four times for 10 min in TBST and incubated with the goat anti-rabbit antibody coupled with alkaline phosphatase (Dianova) (1:10,000 in TBST). The filters were washed in TBST as above, and detection was carried out with nitroblue-tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate as substrates.

Immunohistochemistry—Cryosections (14-µm thick) of perfusion-fixed organs were placed on glass slides coated with gelatin or poly-L-lysine. Nonspecific binding sides were blocked at room temperature for 1 h with 1% bovine serum albumin in PBS. The sections were incubated with anti-Cygb antibodies (1:500 to 1:1000 in PBS) in the blocking solution overnight at 4 °C. The sections were washed 3 x 8 min in PBS and incubated for 90 min at room temperature in the dark with the secondary antibody (goat anti-rabbit IgG coupled to Cy3, Dianova), diluted 1:100 in blocking solution. The sections were washed as described above and embedded in Elvanol polyvinyl alcohol (Mowiol, Calbiochem). In some experiments, the Hoechst dye 33342 (Hoechst, Warrington, PA) was added to the Elvanol to stain the nuclei. The sections were analyzed using an Olympus BX51 research microscope equipped with a digital camera. Images were combined using the Adobe Photoshop 7.0 program, which was also used to adjust image contrast and brightness and to add labels.

Northern Blotting—A commercial Northern blot (Biocat, Heidelberg, Germany) containing normalized amounts of human mRNA was hybridized under standard conditions with a human Cygb cDNA probe, labeled radioactively by random-priming (Roche Applied Science, Mannheim, Germany). Final washing conditions were 65 °C at 0.1x standard saline citrate (SSC). The blot filter was exposed for 24 h using an intensifying screen and Kodak XROmat film.

Transfection of Cygb-GFP Fusion Constructs—For construction of fusions between Cygb and the green fluorescent protein (GFP) gene, the complete human Cygb coding region was first PCR-amplified using primers with restriction enzyme recognition sites attached to their 5'-ends (XhoI and KpnI for the N-terminal Cygb-GFP constructs and XhoI and XbaI for the C-terminal GFP-Cygb constructs). The PCR amplificates were then cut with the appropriate enzymes (New England Biolabs, Frankfurt/M, Germany) and directionally ligated into double-restricted pEGFP-N1 and pEGFP-C1 vectors (Clontech, Heidelberg, Germany), which contain the gene for enhanced green fluorescent protein. We constructed four different gene fusions: CyGB-EGFP-N1 and CyGB-EGFP-C1, in which the gene sequences are directly adjacent to each other, and two constructs containing an additional 6-amino acid spacer (AGC ACC TGG AGC TGC ACC) inserted between the two genes (CyGB-EGFP-N1+spacer and CyGB-EGFP-C1 +spacer) to possibly facilitate an easier folding of the smaller globin protein part. All CyGB-EGFP fusion vectors were transformed into Escherichia coli RR1 {Delta}M15 and verified by DNA sequencing. Plasmid DNA purified using the E.Z.N.A. Plasmid Miniprep Kit I (Peqlab, Erlangen, Germany) was of sufficient quality for successful transfection.

Vero cells (ATCC CCL81) and Hela cells (ATCC CCL2) were routinely cultured in MEM supplemented with 10% fetal bovine serum, 100 IU of penicillin and 100 µg/ml streptomycin at 37 °C in a humidified 5% CO2 incubator. The day prior to transfection cells were plated into 35-mm glass-bottomed dishes (MatTek Corp.) at a density of 20%. On the day of transfection, 1 µg of each DNA was used with 3 µl of FuGENE6 (Roche Applied Science, Mannheim) to transfect the cells according to the manufacturer's instruction. GFP fluorescence was detected and analyzed at the Advanced Light Microscopy Facility at EMBL, Heidelberg. Cells were imaged 18 h after transfection in carbonate-free culture medium equilibrated with 10 mM HEPES pH 7.4 (24) on a Leica DM/IRBE microscope with a x63 NA 1.4PL Apo objective. Confocal images were taken using an UltraView real-time confocal system (PerkinElmer Life Sciences) consisting of a Nikon Eclipse TE200 microscope equipped with a 1.3 NA PlanFluar x100 objective. Images were processed using NIH ImageJ software (Bethesda, MD).

RNA Isolation and Real-time RT-PCR—Total RNA from rat was isolated using the "tri-reagent" kit (Molecular Research Center, Cincinnati, OH), and concentrations were measured using an Amersham Biosciences GeneQuant photometer. The 22-h hypoxic and the normoxic RNA samples represented a pool of four animals each. The 44-h hypoxic sample was a pool of two animals. The RT-PCR experiment was performed twice, with internal duplicate or triplicate reactions (see below). For reverse transcription (RT) we used Superscript II RNase H- reverse transcriptase (Invitrogen, Karlsruhe, Germany) and an oligo(dT15) primer. We adjusted the amount of total RNA to exactly 1 µg per 20 µl of RT reaction. Cygb expression was investigated by a TaqMan assay using primers and a MGB (Minor Groove Binder; Applied Biosystems, Darmstadt, Germany) probe designed by the Primer Express Software (Applied Biosystems, Darmstadt, Germany). The primers we used were QPCR-Cygb-For: 5'-CCA ACT GCG AGG ACG TGG-3' and QPCR-Cygb-Rev: 5'-ACT GGC TGA AGT ACT GCT TGG C-3'. The MGB probe was VIC-labeled at the 5'-end and non-fluorescent quencher (NFQ) was attached to the 3'-end of the probe (QPCR-Cygb-Probe: VIC-5'-CTG GTG AGG TTC TTT GTG-3'-NFQ). To verify the results obtained by the TaqMan method we also used the For and Rev oligonucleotide primers in a SYBR Green assay. For real-time RT-PCR experiments, carried out on an ABI PRISM 7000 SDS, we always used 2 µl of the undiluted cDNA synthesis reaction in a 20-µl volume. Normalization was to rRNA (quantified before by optical density) since >95% of total RNA consists of rRNA. In each PCR we thus used the amount of cDNA that is equivalent to 100 ng of total RNA. Amplification of Cygb was performed using the Quantitect Probe PCR Kit (Qiagen, Hilden, Germany). The final primer concentration during PCR was 0.19 µM (for both TaqMan and SYBR Green assay), the TaqMan probe concentration was 0.2 µM. The cycling protocol was 95 °C for 15 min for the activation of the polymerase, followed by 94 °C for 15 s and 60 °C for 1 min (40 repetitions). The amplification reaction was performed in a regular three-step protocol: 94 °C for 15 s, 60 °C for 30 s, and 72 °C for 30 s, measuring the fluorescence during the last step of each cycle. SYBR Green analyses were followed by dissociation curves in a temperature range from 60 to 92 °C to analyze the specificity of the amplification reactions. Quantification was performed by dividing the mean value of expression of the hypoxic sample through that of the normoxic sample. This quotient represents the factor of higher or lower expression in hypoxic versus normoxic sample. Statistical evaluation was performed by calculating the mean value of the factors of regulation and their standard deviation. The significance of the data was assessed by the two-tailed Student's t test.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Antibodies Against Cygb—Four polyclonal antibodies that are directed against different synthetic Cygb peptides (Fig. 1A) were raised in rabbits. After purification by affinity chromatography, the antibodies ({alpha}Cygb1-4) showed strong positive reaction with recombinant Cygb in Western blotting and in ELISA (see Supplemental Data, Fig. S1). The reaction was inhibited by preadsorption of the antibodies with a 100-fold molar excess of purified recombinant Cygb, demonstrating a specific interaction with the antigen. Three of the antibodies ({alpha}Cygb1-3) gave essentially identical results in immunofluorescence experiments, while no specific immunostaining was observed with the fourth antibody ({alpha}Cygb4) (see Supplemental Data Fig. S2). The antibodies were further tested on various tissues by Western blotting. Only antibodies {alpha}Cygb2 and {alpha}Cygb3 showed the expected bands of 21 kDa in various tissues, which is about the same size as the recombinant protein (Fig. 1B). The antibodies are directed against peptides from the globin D-helix, and the EF-region, respectively (Fig. 1A). The additional bands observed in the Western blot at various positions in some tissues represent nonspecific cross-reactions and do not disappear by preadsorption of the antibody with recombinant Cygb (see Supplemental Data Fig. S3). By contrast, the staining of the Cygb band is specific and was blocked by preadsorption. Antibodies {alpha}Cygb1 and {alpha}Cygb4, directed against the N or C terminus, respectively, showed only weak reactions in Western blot experiments.

Detection of Cygb mRNA and Protein in Mammalian Tissues—The presence of Cygb mRNA in a broad range of tissues was confirmed by Northern blotting (Fig. 2). Using a radioactively labeled cDNA probe, we detected Cygb at different levels in all organs tested. The Cygb mRNA forms a single band of about 2 kb, which agrees well with the size predicted from EST data (accession numbers BC018822 [GenBank] and NM_134268 [GenBank] ).



View larger version (79K):
[in this window]
[in a new window]
  		FIG. 2.
Northern blot analysis of Cygb mRNA in human tissues. A commercial Northern filter containing equal amounts of mRNA (2 µg) from human brain, heart, liver, lung, spleen, stomach, testis, and skeletal muscle was hybridized. Cygb was detected with a radioactively labeled cDNA probe. The size standard (kb) is given on the left side.

 
Examination of various organs with antibodies {alpha}Cygb1-3 showed Cygb protein to be present in distinct cell populations (Fig. 3). In the liver, strong staining was observed in the small hepatic stellate cells (HSCs), which are scattered between the large hepatocytes (Fig. 3, A and C). In addition, fibroblasts forming the connective tissue in the vicinity of blood vessels are decorated with the antibodies. Immunostaining was inhibited after preadsorption of the antibodies with the recombinant antigen (Fig. 3B). No reaction was observed in hepatocytes, endothelial, as well as sinusoidal and red blood cells. Cygb was found in the cytoplasm of the HSCs, while there was no detectable labeling of the nuclei (Fig. 3C). The fibroblasts were decorated with the Cygb antibodies in heart, muscle, colon, kidney, and tendon (Fig. 3, D-G). Particularly strong immunofluorescence was observed in the connective tissue of the Lamina propria mucosae that supports the gut epithelium of the colon (Fig. 3E). In the cartilage of the tracheal wall, about 10% of the chondral cells were found to be stained, which we suspect to be the active chondroblasts, while in the mature chondrocytes no Cygb was detected (Fig. 3H). In the tendon, the matrix fibroblasts were strongly labeled, while less intense staining was present in fibroblasts of the adjacent muscle (Fig. 3I). Cytoglobin expression was also observed in skin fibroblasts (data not shown). The osteoblasts and the osteocytes of the bones were both stained with the antibodies, with the osteocytes showing a weak labeling (Fig. 3J). As in the HSCs (Fig. 3C), anti-Cygb labeling in the fibroblasts, chondroblasts, osteoblasts, and osteocytes was apparently restricted to and uniformly distributed within the cytoplasm, and was also present in cytoplasmic extensions (Fig. 3, D, E, and G-J). No staining of the extracellular matrix or the nuclei of these cells was detected with any of the antibodies. Most other cell types of these organs, such as the endothelial cells in the kidney and the colon (Fig. 3, E and G), the goblet cells of the colon mucosa, and the muscle cells in the heart (Fig. 3D) or the skeletal muscle (Fig. 3I) did not show any signal that was considered to be above background.



View larger version (52K):
[in this window]
[in a new window]
  		FIG. 3.
Immunohistochemical localization of Cygb protein in mouse tissues. Indirect anti-Cygb immunofluorescence was carried out with {alpha}Cygb antibodies on cryosections from liver (A-C), heart (D), gut (E and F), kidney (G), trachea (H), tendon (I), and bone (J). In some sections, the nuclei were stained with Hoechst dye 33342 (green staining; C, D, F). Bright immunofluorescence (red staining) is visible in HSC and the liver fibroblasts (FB) that surround the portal vein, whereas the hepatocytes (HC) are not labeled (A). No immunoreaction was detected in the liver upon preabsorption of the antibody with recombinant Cygb (B). Higher magnification of the liver section shows staining of the cytoplasm of stellate cells (HSC) (C). In the heart, significant cytoplasmic staining was only found in the cardiac fibroblasts (FB), but not in the myocytes (D). The inset on the right-hand side shows a merged figure of the heart tissue counterstained with Hoechst dye 33342. Staining of the colon shows cytoglobin in fibroblasts of the connective tissue in the Lamina propria mucosae (E). Higher magnification of the myenteric plexus in the colon shows cytoplasmic localization of Cygb in the fibroblasts, and cytoplasmic and nuclear staining in the neurons (N) (F). In the kidney, fibroblasts are stained, but not endothelial or other cells (G). Staining of the wall of the trachea show bright immunolabeling of the chondroblasts in the cartilage (CB) (H). In a cross section of the wrist (I), staining of fibroblasts was observed in both muscle (M) and tendon (T). In the bone (J), osteoblasts (OB) show strong and osteocytes (OC) show weak anti-Cygb immunofluorescense. Size bars are given at the lower right-hand side.

 
Furthermore, we found the neurons of the myenteric plexus in the colon to express Cygb (Fig. 3F). However, in these cells Cygb immunolabeling was found in both the cytoplasm (including the nerve processes) and the nuclei. The specificity of this anti-Cygb staining is corroborated by the observation that in the adjacent fibroblasts anti-Cygb immunostaining is exclusively present in the cytoplasm. Cygb was also found in the central nervous system. Cygb-immunoreactive neurons were scattered throughout several regions of the brain. The immunofluorescent signals were strong and clearly distinguishable from the background (Fig. 4). For example in the cerebral cortex, stained neurons were found in all laminae but their number amounted to less than ten percent of the total of neurons. A similar situation was found in the caudate putamen where only a subpopulation of neurons exhibited immunofluorescence. As seen in higher magnifications (Fig. 4, B and C), the signal was present in the cell soma (cytoplasm and nucleus) and in cell processes. Antibodies {alpha}Cygb1 to 3 gave identical staining results in the brain, whereas {alpha}Cygb4 did not show any signal.



View larger version (106K):
[in this window]
[in a new window]
  		FIG. 4.
Cygb expression in the mouse central nervous system. A frontal section of the mouse brain was stained with the {alpha}Cygb1 antibody (A). Overview showing the lateral part of the caudate putamen (CP, left) and area 1 of the cerebral cortex (CC, right). Higher magnifications demonstrate immunofluorescent cell bodies and processes in the caudate putamen (B) and in lamina IV of the cerebral cortex (C).

 
Analysis of Cygb Intracellular Localization by GFP Fusions—The intracellular localization of Cygb was further studied by constructing gene fusions between Cygb and GFP, and transfecting these constructs into cell lines for analyzing the distribution of the fluorescent signal generated upon expression of the fusion genes. N-terminal (Cygb-GFP) as well as C-terminal (GFP-Cygb) fusions were made, and fusions with and without a 6-amino acid spacer between Cygb and GFP were transfected, with all constructs giving the same result. Upon transfection into Hela and Vero cells, GFP signal was distributed equally between the cytoplasm and nucleus (Fig. 5), which argues against a specific nuclear import of Cygb. It is conceivable, however, that the nuclear GFP signal is due to passive diffusion of the fusion protein into the nucleus. The fusion protein size (21 kDa for Cygb plus 27 kDa for GFP) is in the range of the 40-50-kDa cutoff for passive nuclear entry.



View larger version (58K):
[in this window]
[in a new window]
  		FIG. 5.
Transfection of Cygb-GFP fusion constructs. A, a control plasmid, only containing GFP without a Cygb fusion partner. B, GFP signal distribution in Hela cells after transfection and expression of an N-terminal Cygb-GFP fusion construct. C, GFP signal distribution in Vero cells. The fluorescence in Hela and Vero cells is distributed almost equally over the cytoplasm and the nucleus, and indistinguishable from the controls. This argues against a specific nuclear import mediated by Cygb.

 
Cygb mRNA Expression under Hypoxic Conditions—The expression level of Cygb in heart and liver was tested by comparing rats, which had been kept in normoxia or exposed to hypoxia (9% oxygen for 22 or 44 h). Quantitative real time RT-PCR experiments revealed an up-regulation of Cygb mRNA in both organs under hypoxic conditions. In rat heart, Cygb mRNA was up-regulated by a factor of 1.8 ± 0.3 after 22 h and by 2.5 ± 0.9 times after 44 h (Fig. 6). We also observed a 2.2 ± 0.8 and a 2.3 ± 0.5 fold increased expression in rat liver after 22 or 44 h, respectively. The up-regulation of Cygb under hypoxia is significant at the p < 0.01 level. Overall, the mRNA expression was much stronger in heart than in liver (not shown), confirming the Northern blot data.



View larger version (16K):
[in this window]
[in a new window]
  		FIG. 6.
Hypoxia regulation of Cygb mRNA. Quantitative real-time RT-PCR shows that in rat heart and liver Cygb mRNA is up-regulated upon exposure to hypoxic conditions.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
Although globins are certainly among the best studied proteins in terms of function, structure, genetics, and evolution, Cygb was discovered only recently as the fourth member of the vertebrate globin superfamily (13-15). Several functions for Cygb have been proposed (20), but its actual role in animal metabolism is still unknown (13-15, 22).

Localization of Cygb within Tissues and Cells—Cygb was initially observed to be expressed in the HSCs of rat and human liver (15, 16). Here we show that Cygb is also present in cells that form the connective and supportive tissues, represented by the fibroblasts, chondrocytes and bone cells. These cell types have a common ontogenetic origin, as chondrocytes as well as osteocytes differentiate from fibroblasts (25). The exact origin of the HSCs is still a matter of debate (26), although it is generally assumed that HSCs and fibroblasts are related derivatives of the mesoderm (27). Additional Cygb expression was found in distinct neural cell populations of the central and the peripheral nervous systems. Taken together, these data fit well with the apparently ubiquitous presence of Cygb in a broad range of tissues and organs (13, 14, 16).

By applying three antibodies that were independently raised against different Cygb peptides, as well as by using various methods for tissue fixation and immunodetection, we consistently identified the Cygb protein to be localized in the cytoplasm of only distinct cell populations from the non-neuronal tissues. In each case, the specificity of the antibodies and thus the reliability of our results were confirmed by preadsoption experiments, which never showed any immunostaining.

In a recent study Geuens et al. (22) put forward the idea that Cygb is an exclusively nuclear protein, which is present in virtually all cells from a broad range of tissues. Thus both cellular and subcellular distribution of Cygb was proposed to be distinct from our results, e.g. these authors suggested Cygb to be localized in the nuclei of hepatocytes, while we observed Cygb in the liver only in the cytoplasm of HSCs and fibroblasts. However, our data are in agreement with independent immunohistochemical studies on rat and human liver that identified Cygb in the cytoplasm of HSCs (15, 16). Moreover, biochemical experiments on isolated hepatocytes (15) provided convincing evidence against the presence of Cygb in this cell type, neither cytoplasmic nor nuclear. The same biochemical study found Cygb in isolated HSCs, which agrees with our data. Additional evidence against an exclusive nuclear localization of Cygb was provided by the experiments that employed Cygb-GFP fusion constructs, which did not show any active transport of the fusion protein into the nucleus. Calculations using Reinhardt's method (28) predicted Cygb to be a cytoplasmic protein (94.1% reliability). This score is in the same range as that for myoglobin, a protein of undisputed cytoplasmic localization. Given the consistency of our results and their agreement with independent data sets (15, 16), we conclude that Cygb is essentially a cytoplasmic protein in fibroblasts and their derivatives. Thus we cannot confirm the results of Geuens et al. (22), which we consider to be most likely the result of a nonspecific cross-reaction of their polyclonal anti-Cygb antibody with a nuclear protein.

In striking contrast to the situation in the fibroblast-related cells, however, Cygb was found in both the cytoplasm and nuclei of some neurons in the peripheral and central nervous systems. The reliability of this result is confirmed by the fact that all three antibodies ({alpha}Cygb1-3) used for immunohistochemistry showed identical staining patterns, which could be blocked by preadsorption with the antigen. The differential localization of Cygb in neurons versus fibroblasts and related cells is surprising and suggests the existence of a neuron-specific factor that enables the active translocation or passive diffusion of Cygb from the cytoplasm into the nucleus. This might be explained either by a particular role of Cygb in neurons (see below), and/or by the fact that specific physiological conditions are required to initialize the translocation into or the retention within the nucleus.

Implications for Cygb Function—Any evaluation of Cygb function must take the cellular and subcellular distribution of the protein into account. Cygb is found only in distinct cell populations that are, in contrast to the myoglobin- and Ngb-expressing cells (5, 6, 9-12), not generally associated with particular high metabolic rates and thus oxygen consumption. Therefore, a general role of Cygb in facilitating O2 diffusion to the respiratory chain of the mitochondria, as was assumed recently (13, 15, 17), seems unlikely. For similar reasons a role of Cygb as terminal oxidase that supports respiration upon temporary anaerobic conditions may be excluded. Our results are also difficult to reconcile with a function of Cygb in oxygen sensing (22), because there is no obvious explanation why such an O2-sensor should be restricted to the fibroblast-derived cell populations and some neuronal subpopulations. Kawada et al. (15) suggested that Cygb may protect the HSCs from reactive oxygen species (ROS), which are known to be generated e.g. by hepatocytes during inflammation (29). Nevertheless, to the best of our knowledge there is no evidence that Cygb-containing cells are particularly sensitive to ROS.

On the other hand, it is tempting to assume that the particular role of Cygb in fibroblasts, chondroblasts, osteoblasts, and HSCs is linked to collagen synthesis. This process requires O2 and takes place in the cell types that express Cygb. It is conceivable that Cygb supplies molecular oxygen to the prolyl-4-hydroxylase, an iron-containing dioxygenase that employs O2 for the hydroxylation of proline residues in the procollagen molecule (30, 31). The hydroxyproline residue is essential in stabilizing triple helical collagen chains. Although the amount of oxygen consumed by the collagen hydroxylation process is unknown, the degree of collagen hydroxylation in fact depends on the available oxygen (32). The idea of a collagen-linked function of Cygb agrees with the fact that active, collagen-secreting chondroblasts and osteoblasts show a high level of Cygb expression, whereas the inactive, mature chondrocytes and osteocytes that do not synthesize collagen have considerably reduced levels of Cygb. This hypothesis is also in line with the observation that Cygb synthesis is strongly enhanced in activated HSCs of the fibrotic liver (15). Activation of HSCs also occurs during viral infection, wound healing etc (33) and is accompanied by a considerable increase in collagen synthesis (34, 35). It should be noted that the production of collagen mRNA and protein is strongly increased under hypoxia in vitro and in vivo (35-39). As we have shown here, the expression of Cygb is significantly enhanced under hypoxia as well. If our hypothesis is correct, the higher level of Cygb at low oxygen conditions accommodates the increased oxygen demand of the hypoxia-induced collagen synthesis. It remains to be established whether there is a direct interaction of Cygb with the prolyl-4-hydroxylase, or, which seems more likely in analogy to the function of myoglobin, that Cygb facilitates the diffusive transport of O2 to the enzyme.

Nevertheless, other functions of Cygb are still conceivable (20) and compatible with the data, e.g. Cygb may protect the prolyl-4-hydroxylase from noxious ROS or may decompose ROS that might be generated by this enzyme. Cygb may also be involved in a ROS-mediated signaling pathway that activates processes specific for the fibroblast-related cells, e.g. the synthesis of collagen (34, 40).

Cygb is also found in some neurons of brain and the peripheral nervous system, but there is no evidence that collagen is synthesized in these cells. In contrast to the fibroblast-related cell types, the Cygb-containing neurons showed staining of both the cytoplasm and the nuclei. Thus, a distinct function of Cygb in neuronal cells may be assumed. On the one hand, Cygb may also provide O2 to enzymatic reactions. For example, the NO synthases (NOS) require O2 for the production of NO from L-arginine (41). On the other hand, Cygb may be involved in a ROS (NO)-signaling pathway in neurons. Given the phylogenetically ancient position of Cygb among the vertebrate globins (13), future studies will not only elucidate the function of this recently discovered heme protein, but may also provide insights into the evolutionary changes that eventually led to respiratory myoglobins and hemoglobins.


   FOOTNOTES
 
* This work was supported in part by the Deutsche Forschungsgemeinschaft (Grants Bu956/5 and Ha2103/3) and the European Union (QLRT-2001-01548). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

The on-line version of this article (available at http://www.jbc.org) contains Supplementary Data. Back

§§ Joint senior authors. Back

¶¶ To whom correspondence should be addressed: Institute of Zoology, Molecular Animal Physiology, University of Mainz, Müllerweg 6, D-55099 Mainz, Germany. Tel.: 49-6131-39-24477; Fax: 49-6131-39-24652; E-mail: burmeste{at}uni-mainz.de.

1 The abbreviations used are: Ngb, neuroglobin; Cygb, cytoglobin; ELISA, enzyme-linked immunosorbent assay; GFP, green fluorescent protein; HSCs, hepatic stellate cells; PBS, phosphate-buffered saline; ROS, reactive oxygen species; RT, reverse transcription; EST, expressed sequence tag. Back


   ACKNOWLEDGMENTS
 
The authors thank Bettina Ebner for conducting the Northern blot hybridization experiment and Ursula Disque-Kaiser for technical assistance. Requests for material should be addressed to T. H. (hankeln{at}uni-mainz.de) or T. B. (burmeste{at}uni-mainz.de).

Note Added in Proof—Recently, Nakatani et al. (Nakatani, K., Okuyama, H., Shimahara, Y., Saeki, S., Kim, D. H., Nakajima, Y., Seki, S., Kawada, N., and Yoshizato, K. (2004) Lab. Invest. 84, 91-101) also reported the presence of Cygb in the fibroblast cell lineage.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Dickerson, R. E., and Geis, I. (1983) Hemoglobin: Structure, Function, Evolution, and Pathology, Benjamin/Cummings, Menlo Park, CA
  2. Hardison, R. C. (1996) Proc. Natl. Acad. Sci. U. S. A., 93, 5675-5679[Abstract/Free Full Text]
  3. Hardison, R. C. (1998) J. Exp. Biol., 201, 1099-1117[Abstract]
  4. Merx, M. W., Flögel, U., Stumpe, T., Gödecke, A., Decking, U. K., and Schrader, J. (2002) FASEB J. 15, 1077-1079
  5. Wittenberg, B. A., and Wittenberg, J. B. (1989) Annu. Rev. Physiol. 51, 857-878[CrossRef][Medline] [Order article via Infotrieve]
  6. Wittenberg, J. B., and Wittenberg, B. A. (1993) J. Exp. Biol. 206, 2011-2020
  7. Minning, D. M., Gow, A. J., Bonaventura, J., Braun, R., Dewhirst, M., Goldberg, D. E., and Stamler, J. S. (1999) Nature 401, 497-502[CrossRef][Medline] [Order article via Infotrieve]
  8. Flögel, U., Merx, M. W., Gödecke, A., Decking, U. K., and Schrader, J. (2001) Proc. Natl. Acad. Sci. U. S. A., 98, 735-740[Abstract/Free Full Text]
  9. Burmester, T., Weich, B., Reinhardt, S., and Hankeln, T. (2000) Nature 407, 520-523[CrossRef][Medline] [Order article via Infotrieve]
  10. Reuss, S., Saaler-Reinhardt, S., Weich, B., Wystub, S., Reuss, M. H., Burmester, T., and Hankeln, T. (2002) Neuroscience 115, 645-656[CrossRef][Medline] [Order article via Infotrieve]
  11. Wystub, S., Laufs, T., Schmidt, M., Burmester, T., Maas, U., Saaler-Reinhardt, S., Hankeln, T., and Reuss, S. (2003) Neurosci. Lett. 346, 114-116[CrossRef][Medline] [Order article via Infotrieve]
  12. Schmidt, M., Gie{beta}l, A., Laufs, T., Hankeln, T., Wolfrum, U., and Burmester, T. (2003) J. Biol. Chem. 278, 1932-1935[Abstract/Free Full Text]
  13. Burmester, T., Ebner, B., Weich, B., and Hankeln, T. (2002) Mol. Biol. Evol. 19, 416-421[Abstract/Free Full Text]
  14. Trent, J. T. III and Hargrove, M. S. (2002) J. Biol. Chem. 277, 19538-19545[Abstract/Free Full Text]
  15. Kawada, N., Kristensen, D. B., Asahina, K., Nakatani, K., Minamiyama, Y., Seki, S., and Yoshizato, K. (2001) J. Biol. Chem. 276, 25318-25323[Abstract/Free Full Text]
  16. Asahina, K., Kawada, N., Kristensen, D. B., Nakatani, K., Seki, S., Shiokawa, M., Tateno, C., Obara, M., and Yoshizato, K. (2002) Biochim. Biophys. Acta 1577, 471-475[Medline] [Order article via Infotrieve]
  17. Sawai, H., Kawada, N., Yoshizato, K., Nakajima, H., Aono, S., and Shiro, Y. (2003) Biochemistry 42, 5133-5142[CrossRef][Medline] [Order article via Infotrieve]
  18. Hamdane, D., Kiger, L., Dewilde, S., Green, B. N., Pesce, A., Uzan, J., Burmester, T., Hankeln, T. Bolognesi, M., Moens, L., and Marden, M. C. (2003) J. Biol. Chem. 278, 51713-51721[Abstract/Free Full Text]
  19. Kundu, S., Premer, S. A., Hoy, J. A., Trent, J. T., III, and Hargrove, M. S. (2003) Biophys. J. 84, 3931-3940[Abstract/Free Full Text]
  20. Pesce, A., Bolognesi, M., Ascenzi, P., Bocedi, A., Dewilde, S., Moens, L., Hankeln, T., and Burmester, T. (2002) EMBO Rep. 3, 1146-1151[CrossRef][Medline] [Order article via Infotrieve]
  21. de Sanctis, D., Dewilde, S., Pesce, A., Ascenzi, P., Burmester, T., Hankeln, T., Moens, L., and Bolognesi, M. (2003) Acta Crystallogr. Sect. D. 59, 1285-1287[CrossRef][Medline] [Order article via Infotrieve]
  22. Geuens, E., Brouns, I., Flamez, D., Dewilde, S., Timmermans, J. P., and Moens, L. (2003) J. Biol. Chem. 278, 30417-30420[Abstract/Free Full Text]
  23. McLean, I. W., and Nakane, P. K. (1974) J. Histochem. Cytochem. 22, 1077-1083[Abstract]
  24. Shima, D. T., Scales, S. J., Kreis, T. E., and Pepperkok, R. (1999) Curr. Biol. 9, 821-824[CrossRef][Medline] [Order article via Infotrieve]
  25. Rogers, A. W. (1983) Cells and Tissues-An Introduction to Histology and Cell Biology, Academic Press, New York
  26. Eng, F. J., and Friedman, S. L. (2000) Am. J. Physiol. Gastrointest. Liver Physiol. 279, G7-G11[Abstract/Free Full Text]
  27. Spagnoli, F. M., Amicone, L., Tripodi, M., and Weiss, M. C. (1998) J. Cell Biol. 143, 1101-1112[Abstract/Free Full Text]
  28. Reinhardt, A., and Hubbard, T. (1998) Nucleic Acids Res. 26, 2230-2236[Abstract/Free Full Text]
  29. Maher, J. J. (1999) Alcohol Clin. Exp. Res. 23, 917-921[Medline] [Order article via Infotrieve]
  30. Pihlajaniemi, T., Myllyla, R., and Kivirikko, K. I. (1991) J. Hepatol. 13, S2-S7
  31. Kivirikko, K. I., and Myllyharju, J. (1998) Matrix Biol. 16, 357-368[CrossRef][Medline] [Order article via Infotrieve]
  32. Yen, E. H., Sodek, J., and Melcher, A. H. (1979) Biochem. J. 178, 605-612[Medline] [Order article via Infotrieve]
  33. Reeves, H. L., and Friedman, S. L. (2002) Front. Biosci. 7, d808-826[Medline] [Order article via Infotrieve]
  34. Arthur, M. J. (2000) Am. J. Physiol. Gastrointest. Liver Physiol. 279, G245-249[Abstract/Free Full Text]
  35. Nieto, N., Friedman, S. L., and Cederbaum, A. I. (2002) J. Biol. Chem. 277, 9853-9864[Abstract/Free Full Text]
  36. Falanga, V., Martin, T. A., Takagi, H., Kirsner, R. S., Helfman, T., Pardes, J., and Ochoa, M. S. (1993) J. Cell. Physiol. 157, 408-412[CrossRef][Medline] [Order article via Infotrieve]
  37. Ostadal, B., Kolar, F., Pelouch, V., and Widimsky, J. (1995) Physiol. Res. 44, 45-51[Medline] [Order article via Infotrieve]
  38. Takahashi, Y., Takahashi, S., Shiga, Y., Yoshimi, T., and Miura, T. (2000) J. Biol. Chem. 275, 14139-14146[Abstract/Free Full Text]
  39. Horino, Y., Takahashi, S., Miura, T., and Takahashi, Y. (2002) Life Sci. 71, 3031-3045[CrossRef][Medline] [Order article via Infotrieve]
  40. Svegliati Baroni, G., D'Ambrosio, L., Ferretti, G., Casini, A., Di Sario, A., Salzano, R., Ridolfi, F., Saccomanno, S., Jezequel, A. M., and Benedetti, A. (1998) Hepatology 27, 720-726[CrossRef][Medline] [Order article via Infotrieve]
  41. Leone, A. M., Palmer, R. M., Knowles, R. G., Francis, P. L., Ashton, D. S., and Moncada, S. (1991) J. Biol. Chem. 266, 23790-23795[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
N. Shivapurkar, V. Stastny, N. Okumura, L. Girard, Y. Xie, C. Prinsen, F. B. Thunnissen, I. I. Wistuba, B. Czerniak, E. Frenkel, et al.
Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene
Cancer Res., September 15, 2008; 68(18): 7448 - 7456.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
J. Ostojic, S. Grozdanic, N. A. Syed, M. S. Hargrove, J. T. Trent III, M. H. Kuehn, R. H. Kardon, Y. H. Kwon, and D. S. Sakaguchi
Neuroglobin and Cytoglobin Distribution in the Anterior Eye Segment: A Comparative Immunohistochemical Study
J. Histochem. Cytochem., September 1, 2008; 56(9): 863 - 872.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
N. J. Hodges, N. Innocent, S. Dhanda, and M. Graham
Cellular protection from oxidative DNA damage by over-expression of the novel globin cytoglobin in vitro
Mutagenesis, July 1, 2008; 23(4): 293 - 298.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Sheffer, O. Leon, J. H. Pinthus, A. Nagler, Y. Mor, O. Genin, M. Iluz, N. Kawada, K. Yoshizato, and M. Pines
Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect
Mol. Cancer Ther., February 1, 2007; 6(2): 570 - 577.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
P. P.A. Mammen, J. M. Shelton, Q. Ye, S. B. Kanatous, A. J. McGrath, J. A. Richardson, and D. J. Garry
Cytoglobin Is a Stress-responsive Hemoprotein Expressed in the Developing and Adult Brain
J. Histochem. Cytochem., December 1, 2006; 54(12): 1349 - 1361.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
G. Xinarianos, F. E. McRonald, J. M. Risk, N. L. Bowers, G. Nikolaidis, J. K. Field, and T. Liloglou
Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer
Hum. Mol. Genet., July 1, 2006; 15(13): 2038 - 2044.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
A. Roesner, T. Hankeln, and T. Burmester
Hypoxia induces a complex response of globin expression in zebrafish (Danio rerio)
J. Exp. Biol., June 1, 2006; 209(11): 2129 - 2137.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
F. E. McRonald, T. Liloglou, G. Xinarianos, L. Hill, L. Rowbottom, J. E. Langan, A. Ellis, J. M. Shaw, J. K. Field, and J. M. Risk
Down-regulation of the cytoglobin gene, located on 17q25, in tylosis with oesophageal cancer (TOC): evidence for trans-allele repression
Hum. Mol. Genet., April 15, 2006; 15(8): 1271 - 1277.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Ostojic, D. S. Sakaguchi, Y. de Lathouder, M. S. Hargrove, J. T. Trent III, Y. H. Kwon, R. H. Kardon, M. H. Kuehn, D. M. Betts, and S. Grozdanic
Neuroglobin and cytoglobin: oxygen-binding proteins in retinal neurons.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1016 - 1023.
[Abstract] [Full Text] [PDF]